Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Parcel Service
UPS
|
+$428M |
| 2 |
DexCom
DXCM
|
+$384M |
| 3 |
WIX.com
WIX
|
+$359M |
| 4 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$254M |
| 5 |
Caesars Entertainment
CZR
|
+$246M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.14B |
| 2 |
Microchip Technology
MCHP
|
+$535M |
| 3 |
Merck
MRK
|
+$512M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$444M |
| 5 |
Illumina
ILMN
|
+$413M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.59% |
| 2 | Healthcare | 18.35% |
| 3 | Consumer Discretionary | 11.3% |
| 4 | Financials | 10.45% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
General Motors
GM
$81.5B
| $47.3M | 0.02% |
798,592
-1,860,917
| -70% | -$109M |
|
577
Acadia Pharmaceuticals
ACAD
$4.43B
| $47.1M | 0.02% |
1,929,131
-3,448,245
| -64% | -$77.8M |
|
578
Fox Class B
FOX
$21.7B
| $47M | 0.02% |
1,336,016
-100,584
| -7% | -$3.64M |
|
579
Stem
STEM
$48.1M
| $47M | 0.02% |
+65,293
| New | +$35.5M |
|
580
Qiagen
QGEN
$8.62B
| $47M | 0.02% |
916,413
+180,346
| +25% | +$9.31M |
|
581
Veeva Systems
VEEV
$32.8B
| $46.7M | 0.02% |
150,335
-281,317
| -65% | -$78.4M |
|
582
Keurig Dr Pepper
KDP
$42B
| $46.6M | 0.02% |
1,321,903
+1,015,888
| +332% | +$36.2M |
|
583
3M
MMM
$94.1B
| $46.6M | 0.02% |
280,466
-221,410
| -44% | -$36.9M |
|
584
Haemonetics
HAE
$3.76B
| $46.1M | 0.02% |
+692,072
| New | +$49M |
|
585
CryoPort
CYRX
$774M
| $46M | 0.02% |
729,664
-23,447
| -3% | -$1.32M |
|
586
Apple Hospitality REIT
APLE
$3.96B
| $46M | 0.02% |
3,015,634
+639,673
| +27% | +$9.94M |
|
587
Douglas Emmett
DEI
$2.01B
| $46M | 0.02% |
1,368,022
+491,677
| +56% | +$16.7M |
|
588
QuidelOrtho
QDEL
$1.15B
| $46M | 0.02% |
359,020
+210,097
| +141% | +$24.7M |
|
589
Watts Water Technologies
WTS
$11.5B
| $45.9M | 0.02% |
314,805
+28
| +0% | +$3.7K |
|
590
O'Reilly Automotive
ORLY
$75.7B
| $45.9M | 0.02% |
1,215,135
-8,760
| -0.7% | -$314K |
|
591
Aligos Therapeutics
ALGS
$26.1M
| $45.8M | 0.02% |
90,391
+1,189
| +1% | +$758K |
|
592
Wells Fargo
WFC
$263B
| $45.7M | 0.02% |
1,008,338
-69,981
| -6% | -$3.12M |
|
|
SILK
593
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $45.6M | 0.02% |
953,362
-52
| -0% | -$2.65K |
|
594
Coursera
COUR
$1.71B
| $45.6M | 0.02% |
1,153,374
+153,374
| +15% | +$6.6M |
|
595
Palo Alto Networks
PANW
$261B
| $45M | 0.02% |
728,178
-377,460
| -34% | -$22.4M |
|
596
PNC Financial Services
PNC
$100B
| $44.9M | 0.02% |
235,494
+111,135
| +89% | +$20.9M |
|
597
Marqeta
MQ
$1.92B
| $44.9M | 0.02% |
+399,986
| New | +$47.7M |
|
598
Ingevity
NGVT
$2.63B
| $44.9M | 0.02% |
551,925
+185,185
| +50% | +$14.9M |
|
599
Corteva
CTVA
$59.6B
| $44.6M | 0.02% |
1,005,650
-79,132
| -7% | -$3.66M |
|
600
GDS Holdings
GDS
$6.08B
| $44.6M | 0.02% |
567,604
-4,109
| -0.7% | -$319K |
|
Similar funds
Janus Henderson Group's Q2 2021 Portfolio in Review
As of Q2 2021, Janus Henderson Group held 1,725 positions worth $234B, up 6.7% from $219B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2021 filing shows 172 new, 741 increased, 667 reduced and 123 closed positions. Its largest new stake was Centessa Pharmaceuticals: 5,680,933 shares worth $120M. The largest sale was Apple, an estimated $1.14B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2021 buy was Centessa Pharmaceuticals: 5,680,933 shares worth $120M.
- Janus Henderson Group added most to United Parcel Service in Q2 2021, an estimated $428M increase.
- Janus Henderson Group's biggest Q2 2021 reduction was Apple, cutting an estimated $1.14B.
- Janus Henderson Group fully exited PRA Health Sciences, Inc. in Q2 2021, selling an estimated $368M.
- Janus Henderson Group's ten largest holdings make up 23% of its $234B portfolio in Q2 2021.
- Janus Henderson Group opened 172 new positions and closed 123 in Q2 2021.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $234B.
Based on Janus Henderson Group's 13F filing for Q2 2021, filed 16 Aug 2021.